June 30, 2026 · Menopause (New York, N.Y.) · DOI: 10.1097/GME.0000000000002840

Regulatory awareness, counseling priorities, and treatment choices in menopausal hormone therapy: a cross-sectional survey of obstetricians and gynecologists

Listen to this summary

The authors aimed to investigate the relationship between clinicians' awareness of a recent FDA regulatory communication on menopausal hormone therapy (MHT) and any subsequent changes in their clinical practices, counseling priorities, and treatment choices. The study found that regulatory awareness did not significantly correlate with reported changes in clinical practice; instead, factors such as the use of standard hormone therapy protocols, perceptions of compounded bioidentical hormone therapy, and prioritization of patient preferences were more influential. Additionally, while awareness impacted treatment choices in vignette scenarios, it did not translate to self-reported changes in routine practice.

Erhan Hüseyin Cömert, Ümran Karabulut Doğan, Ayşe Ecenaz Yıldırım, Bayram Özağaç, Telal Doğruel, Ozan Doğa

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play